PATENT CLAIM ANALYSIS

Application Number: 16103649
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "002300"]

Abstract:
The present disclosure provides hNGAL muteins that bind a pyoverdine family member or pyochelin and can be used in various application including pharmaceutical applications, for example, to inhibit or reduce growth of  P. aeruginosa . The present disclosure also concerns methods of making one or more pyoverdine- or pyochelin-binding muteins described herein as well as compositions comprising one or more of such muteins. The present disclosure further relates to nucleic acid molecules encoding such muteins and to methods for generation of such muteins and nucleic acid molecules. In addition, the application discloses therapeutic and/or diagnostic uses of these muteins as well as compositions comprising one or more of such muteins.

Claim (Index 21):
A host cell containing a nucleic acid molecule of  claim 20 .

Metadata:
- Claim Count in Document: 14.0
- Percentile: 96.0
- Lexical Diversity: 1.75758
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15814737', '15726577', '15726163', '15727087', '15203613']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8931902569718382
- 35 USC 102 Novelty (BERT): 0.6228612313545367
- Combined Prediction Score: 0.8661573544101081
- Mean Citation Score: 777.057688
- Max Citation Score: 824.20074
- Similarity Product: 497.7321867265212

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test